NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
1.210
-0.015 (-1.22%)
At close: Nov 20, 2024, 4:00 PM
1.250
+0.040 (3.31%)
After-hours: Nov 20, 2024, 5:23 PM EST
NRx Pharmaceuticals Stock Forecast
NRXP's stock price has decreased by -60.88% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts with 12-month price forecasts for NRx Pharmaceuticals stock have an average target of 31.33, with a low estimate of 19 and a high estimate of 44. The average target predicts an increase of 2,489.26% from the current stock price of 1.21.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for NRXP stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 2 | 2 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| EF Hutton | EF Hutton | Strong Buy Maintains $31 | Strong Buy | Maintains | $31 | +2,461.98% | Oct 30, 2024 |
| EF Hutton | EF Hutton | Strong Buy Initiates $31 | Strong Buy | Initiates | $31 | +2,461.98% | Oct 21, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $43 → $44 | Strong Buy | Maintains | $43 → $44 | +3,536.36% | Sep 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $2 → $19 | Strong Buy | Maintains | $2 → $19 | +1,470.25% | Aug 5, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $50 → $43 | Strong Buy | Maintains | $50 → $43 | +3,453.72% | Jun 7, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
50.06M
EPS This Year
-2.85
from -3.98
EPS Next Year
-1.30
from -2.85
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | n/a | 112.6M | 189.3M |
| Avg | n/a | 50.1M | 183.9M |
| Low | n/a | n/a | 176.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | 278.2% |
| Avg | - | - | 267.4% |
| Low | - | - | 253.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -2.40 | -0.49 | 1.87 |
| Avg | -2.85 | -1.30 | 1.82 |
| Low | -3.19 | -2.34 | 1.74 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.